GROUP ONE TRADING, L.P. - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is and the CUSIP is 00461U955. A total of 5 filers reported holding ACLARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,037,090
+440.6%
151,400
+718.4%
0.00%
+200.0%
Q2 2023$191,845
-73.6%
18,500
-79.4%
0.00%
-66.7%
Q1 2023$726,482
+5089.2%
89,800
+8880.0%
0.00%
Q2 2022$14,000
+1300.0%
1,000
+900.0%
0.00%
Q4 2021$1,000
-97.1%
100
-94.7%
0.00%
Q3 2021$34,000
-92.9%
1,900
-93.0%
0.00%
-100.0%
Q2 2021$478,000
+59.3%
27,200
+128.6%
0.00%
Q1 2021$300,000
+311.0%
11,900
+5.3%
0.00%
Q4 2020$73,000
+7200.0%
11,300
+1783.3%
0.00%
Q4 2019$1,0000.0%600
+20.0%
0.00%
Q3 2019$1,000
-97.9%
500
-97.7%
0.00%
Q2 2019$47,00021,5000.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Altium Capital Management LP 175,000$1,198,7500.62%
GROUP ONE TRADING, L.P. 151,400$1,037,0900.00%
SIMPLEX TRADING, LLC 227,700$1,5590.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
JANE STREET GROUP, LLC 21,700$148,6450.00%
View complete list of ACLARIS THERAPEUTICS INC shareholders